CogState

CogState Revenue

The The revenue of CogState (CGS.AX) as of Oct 17, 2026 is 53.09 M USD. In the previous year, The revenue was 43.43 M USD — a change of 22.25% (higher).

Revenue

53.09 MUSD

YoY

22.25%

Last updated:

In 2025, CogState's sales reached 53.09 M USD, a 22.25% difference from the 43.43 M USD sales recorded in the previous year.

Over the last 19 years CogState grew revenue by 20.0% annually, reaching 53.09 M USD.

The CogState Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2023
40.45 M USD
Jan 1, 2024
43.43 M USD
Jan 1, 2025
53.09 M USD
Jan 1, 2026 (e)
128.65 M USD
Jan 1, 2027 (e)
108.90 M USD
Jan 1, 2028 (e)
124.70 M USD
Jan 1, 2029 (e)
142.14 M USD
Jan 1, 2030 (e)
150.15 M USD
The CogState Revenue history
YEARRevenueYoY
est150.15 MUSD+5.63%
est142.14 MUSD+13.99%
est124.70 MUSD+14.50%
est108.90 MUSD-15.35%
est128.65 MUSD+142.32%
53.09 MUSD+22.25%
43.43 MUSD+7.36%
40.45 MUSD-10.18%
45.03 MUSD+37.73%
32.70 MUSD+43.51%
22.78 MUSD+4.25%
21.85 MUSD-24.63%
29.00 MUSD+9.58%
26.46 MUSD+39.34%
18.99 MUSD+78.18%
10.66 MUSD-6.68%
11.42 MUSD-11.61%
12.92 MUSD+2.95%
12.55 MUSD+54.37%
8.13 MUSD-3.67%
8.44 MUSD+35.26%
6.24 MUSD+81.40%
3.44 MUSD+78.24%
1.93 MUSD+16.27%
1.66 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CogState Revenue

CogState Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
40.45 M USD
3.11 M USD
3.57 M USD
Jan 1, 2024
43.43 M USD
7.07 M USD
5.45 M USD
Jan 1, 2025
53.09 M USD
13.07 M USD
10.14 M USD
Jan 1, 2026 (e)
128.65 M USD
23.06 M USD
16.22 M USD
Jan 1, 2027 (e)
108.90 M USD
30.91 M USD
22.41 M USD
Jan 1, 2028 (e)
124.70 M USD
38.83 M USD
27.76 M USD
Jan 1, 2029 (e)
142.14 M USD
47.36 M USD
33.64 M USD
Jan 1, 2030 (e)
150.15 M USD
26.65 M USD
25.73 M USD

CogState Margins

CogState stock margins

The CogState margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CogState. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CogState.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
51.04 %
7.68 %
8.82 %
Jan 1, 2024
55.96 %
16.29 %
12.55 %
Jan 1, 2025
60.53 %
24.63 %
19.11 %
Jan 1, 2026 (e)
60.53 %
17.92 %
12.61 %
Jan 1, 2027 (e)
60.53 %
28.38 %
20.58 %
Jan 1, 2028 (e)
60.53 %
31.14 %
22.26 %
Jan 1, 2029 (e)
60.53 %
33.32 %
23.67 %
Jan 1, 2030 (e)
60.53 %
17.75 %
17.14 %

CogState Stock analysis

What does CogState do? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState is one of the most popular companies on Eulerpool.

Revenue Details

Understanding CogState's Sales Figures

The sales figures of CogState originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing CogState’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize CogState's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in CogState’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about CogState stock

The revenue of CogState is 53.09 M USD in 2025.

The revenue of CogState changed from 43.43 M USD to 53.09 M USD, representing a 22.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The revenue CogState since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's CogState historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CogState

All Key Metrics — CogState